血清Nrf2、SIRT3、PLIN5与慢性心力衰竭病人左心室重构及预后的关系

    Study on the relationship between serum Nrf2, SIRT3, PLIN5 and left ventricular remodeling and prognosis in patients with chronic heart failure

    • 摘要:
      目的: 探讨血清核因子E2相关因子2(Nrf2)、沉默调节蛋白3(SIRT3)、脂滴包被蛋白5(PLIN5)与慢性心力衰竭(CHF)病人左心室重构(LVR)的相关性及其对预后的预测价值。
      方法: 选取200例CHF病人为观察组,另选同期100名健康体检者为对照组。比较2组血清Nrf2、SIRT3、PLIN5水平及LVR指标左室舒张末期后壁厚度(LVPWT)、舒张末期室间隔厚度(IVST)、左室质量指数(LVMI),Pearson法分析血清Nrf2、SIRT3、PLIN5与心室重构的相关性,随访9个月,根据预后情况分为预后良好及预后不良病人,比较不同预后病人基线资料及血清Nrf2、SIRT3、PLIN5水平,logistic回归分析血清Nrf2、SIRT3、PLIN5与CHF病人预后的关系,受试者工作特征(ROC)曲线分析血清Nrf2、SIRT3、PLIN5预测预后的效能。
      结果: 观察组血清Nrf2、SIRT3、PLIN5水平低于对照组,LVPWT、IVST、LVMI值高于对照组 (P < 0.01);Pearson法分析显示,血清Nrf2、SIRT3、PLIN5水平与LVR指标LVPWT、IVST、LVMI值均呈负相关关系(P < 0.05);不同预后病人肌钙蛋白Ⅰ(cTnⅠ)、脑钠肽(BNP)、Nrf2、SIRT3、PLIN5水平比较差异有统计学意义 (P < 0.05);logistic回归分析显示,校正相关混杂因素后,Nrf2、SIRT3、PLIN5仍是CHF病人预后的影响因素(P < 0.05);ROC曲线显示,Nrf2、SIRT3、PLIN5预测预后不良的曲线下面积(AUC)分别为0.774、0.796、0.757,联合预测的AUC为0.933(0.888 ~ 0.964),明显高于三指标单一预测效能(Z = 3.763、3.022、3.589,P = 0.000、0.003、0.000)。
      结论: 血清Nrf2、SIRT3、PLIN5水平均与CHF病人LVR指标具有一定相关性,联合检测对预后不良具有一定预测价值,可为临床评估LVR、预测预后提供参考,并可指导临床决策。

       

      Abstract:
      Objective To investigate the correlation between serum nuclear factor E2-related factor 2 (Nrf2), silent regulatory protein 3 (SIRT3), perilipin 5 (PLIN5) and left ventricular remodeling (LVR) in patients with chronic heart failure (CHF), and its predictive value for prognosis.
      Methods Two hundred patients with CHF were selected as the observation group, and another 100 healthy individuals undergoing physical examinations during the same period were selected as the control group. The levels of serum Nrf2, SIRT3, PLIN5 and LVR indicatorsleft ventricular end-diastolic posterior wall thickness (LVPWT), end-diastolic ventricular septal thickness (IVST), left ventricular mass index (LVMI) were compared between two groups. The Pearson method was used to analyze the correlation between serum Nrf2, SIRT3, PLIN5 and ventricular remodeling. The patients were followed up for 9 months, and divided into the good prognosis and poor prognosis patients according to the prognosis. The baseline data and levels of serum Nrf2, SIRT3 and PLIN5 of patients with different prognoses were compared. The logistic regression was used to analyze the relationship between serum Nrf2, SIRT3, PLIN5 and prognosis of CHF patients. The receiver operating characteristic (ROC) curve was used to analyze the efficacy of serum Nrf2, SIRT3 and PLIN5 in predicting prognosis.
      Results The levels of serum Nrf2, SIRT3 and PLIN5 in the observation group were lower than those in control group, while the values of LVPWT, IVST and LVMI were higher than those in control group (P < 0.01). The results of Pearson analysis showed that the levels of serum Nrf2, SIRT3 and PLIN5 were negatively correlated with the values of LVR indicators LVPWT, IVST, and LVMI (P < 0.05). There were statistically significant differences in the levels of troponin Ⅰ (cTnⅠ), brain natriuretic peptide (BNP), Nrf2, SIRT3 and PLIN5 among patients with different prognostic conditions (P < 0.05). The results of logistic regression analysis showed that after adjusting for related confounding factors, the Nrf2, SIRT3 and PLIN5 were still the influencing factors for the prognosis of CHF patients (P < 0.05). The ROC curve showed that the area under the curve (AUC) of Nrf2, SIRT3 and PLIN5 for predicting poor prognosis was 0.774, 0.796, and 0.757, respectively, and the AUC of the combined prediction was 0.933 (0.888−0.964). It was significantly higher than the single prediction efficacy of the three indicators (Z = 3.763, 3.022, 3.589, P = 0.000, 0.003, 0.000).
      Conclusions The levels of serum Nrf2, SIRT3 and PLIN5 all have certain correlations with the LVR index of CHF patients. The combined detection has certain predictive value for poor prognosis, which can provide a reference for clinical assessment of LVR and prognosis prediction, and also guide clinical decision-making.

       

    /

    返回文章
    返回